1、 Product introduction |
Chinese Name | English Name | Declaration Type | Department | ReportableDosage Form | Declaration Progress | Strength | CAS |
美沙拉嗪 | Mupirocin | 5+4 | Gastroenterology | Tablets, enteric coated tablets, sustained-release granules, sustained-release tablets, suppositories, enteric coated tablets, enemas | Already accepted | 0.25mg、55mg、250mg、500mg、1g、60ml、4g | 89-57-6 |
【Indication】
Anti ulcerative colitis.
【Reportable Dosage Form &Strength】
Tablets: 0.25g, 55mg; enteric coated tablets: 250mg, 500mg 'sustained-release granules: 500mg; sustained-release tablets: 500mg; suppository: 1g, 500mg; enteric coated tablets: 500mg; enema: 60ml: 4g
【Development Progress】
Already accepted
2、Domestic Declaration
Declaration Type | Reportable Dosage Form | Number of Declared Preparations | Number of Existing Preparation Enterprises |
5+4 | Tablet, enteric-coated tablet, sustained-release granule, sustained-release tablet, suppository, enteric-coated film tablet, enema | Enteric coated granules: 1 imported Enteric coated sustained release tablets: 1 imported Enteric coated tablets: 3 domestic Enema fluid: 1 domestic, suppository: 2 imported Slow release granules: 2 imported and 1 domestic Sustained release tablets: 3 imported Controlled release capsule: 1 domestic | Enteric coated tablets: 1 imported, 3 domestic Enema fluid: 1 imported Sustained release tablets: 1 imported Suppository: 2 imported and 1 domestic Slow release granules: 1 imported and 1 domestic |
![Brinzolamide 布林佐胺 CAS号:138890-62-7 Brinzolamide 布林佐胺 CAS号:138890-62-7]()
Guangzhou Tosun Pharmaceutical Ltd
FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663
Tel: +86-20-66392521; Fax: +86-20-66392525